Literature DB >> 12477753

Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques.

K Egger1, M Werner, A Meining, R Ott, H-D Allescher, H Höfler, M Classen, T Rösch.   

Abstract

BACKGROUND AND AIMS: Endoscopic surveillance including stepwise four quadrant biopsies (4QB) is still regarded as the standard approach in patients with Barrett's oesophagus (BO). Several methods such as dye staining with methylene blue (MB) and tissue autofluorescence (AF) have been advocated to reduce the number of biopsies. We assessed their sensitivity and specificity compared with the standard approach-that is, endoscopy with 4QB-in the surveillance of a mixed BO population. PATIENTS AND METHODS: Thirty five consecutive BO patients (mean age 64.9 years; 30 men, five women) were included in the study. AF endoscopy was followed by high resolution video endoscopy (VE) plus tissue staining with 0.5% MB. Biopsies were taken from any suspicious area found on any of the above tests, in addition to 4QB every 2 cm. The results were classified as either positive or negative for the various tests used. Histopathological results were used as the reference standard.
RESULTS: In the 35 study patients, a total of 345 biopsies showed low grade dysplasia (LGD) in 88 biopsies, high grade dysplasia (HGD) in 19 biopsies, and carcinoma in 12 biopsies. The sensitivity and specificity rates for AF and MB for the diagnosis of cancer or dysplasia versus BO mucosa without dysplasia were 21%/91% and 37%/91%, respectively. 4QB revealed five cancer/HGD areas and 76 LGD areas not detected by AF, MB, or VE. The additional yield of MB and AF over VE with 4QB concerned only one HGD area (in the vicinity of a cancer) and seven LGD areas.
CONCLUSIONS: Due to their low sensitivity, AF and MB are not suitable techniques for reducing the high numbers of routine biopsies needed for finding additional foci of HGD or cancer. Careful endoscopic observation and stepwise four quadrant biopsy therefore still represent the gold standard for surveillance of Barrett's oesophagus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477753      PMCID: PMC1773515          DOI: 10.1136/gut.52.1.18

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  [Fluorescence endoscopy in gastroenterology].

Authors:  H Messmann
Journal:  Z Gastroenterol       Date:  2000-01       Impact factor: 2.000

Review 2.  Optical coherence tomography in the gastrointestinal tract.

Authors:  S Brand; J M Poneros; B E Bouma; G J Tearney; C C Compton; N S Nishioka
Journal:  Endoscopy       Date:  2000-10       Impact factor: 10.093

3.  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.

Authors:  B J Reid; P L Blount; Z Feng; D S Levine
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

4.  Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.

Authors:  H Messmann; R Knüchel; W Bäumler; A Holstege; J Schölmerich
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

Review 5.  The value of fluorescence techniques in gastrointestinal endoscopy--better than the endoscopist's eye? II: The North American experience.

Authors:  N E Marcon; B C Wilson
Journal:  Endoscopy       Date:  1998-05       Impact factor: 10.093

6.  Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus.

Authors:  M I Canto; S Setrakian; J Willis; A Chak; R Petras; N R Powe; M V Sivak
Journal:  Gastrointest Endosc       Date:  2000-05       Impact factor: 9.427

7.  Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice?

Authors:  S J Spechler
Journal:  Ann Intern Med       Date:  1987-06       Impact factor: 25.391

8.  Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low-grade dysplasia.

Authors:  L M Gangarosa; S Halter; H Mertz
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

9.  Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy.

Authors:  M B Wallace; L T Perelman; V Backman; J M Crawford; M Fitzmaurice; M Seiler; K Badizadegan; S J Shields; I Itzkan; R R Dasari; J Van Dam; M S Feld
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

10.  In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus, and adenocarcinoma of the esophagus.

Authors:  S Jäckle; N Gladkova; F Feldchtein; A Terentieva; B Brand; G Gelikonov; V Gelikonov; A Sergeev; A Fritscher-Ravens; J Freund; U Seitz; S Schröder; N Soehendra
Journal:  Endoscopy       Date:  2000-10       Impact factor: 10.093

View more
  27 in total

1.  S, m, l, xl.

Authors:  T Wang; G Triadafilopoulos
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 2.  Optical biopsy: a new frontier in endoscopic detection and diagnosis.

Authors:  Thomas D Wang; Jacques Van Dam
Journal:  Clin Gastroenterol Hepatol       Date:  2004-09       Impact factor: 11.382

Review 3.  Advanced endoscopic imaging in Barrett's oesophagus: a review on current practice.

Authors:  Rajvinder Singh; SweeLin Chen Yi Mei; Sandeep Sethi
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

Review 4.  Screening and surveillance for Barrett's esophagus: current issues and future directions.

Authors:  Sung E Choi; Chin Hur
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

Review 5.  Current Strategies in the management of Barrett's esophagus.

Authors:  Kenneth K Wang
Journal:  Curr Gastroenterol Rep       Date:  2005-06

6.  Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus.

Authors:  John A Evans; John M Poneros; Brett E Bouma; Jason Bressner; Elkan F Halpern; Milen Shishkov; Gregory Y Lauwers; Mari Mino-Kenudson; Norman S Nishioka; Guillermo J Tearney
Journal:  Clin Gastroenterol Hepatol       Date:  2006-01       Impact factor: 11.382

Review 7.  Barrett's esophagus: diagnosis and management.

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2017-01-18       Impact factor: 9.427

Review 8.  Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative.

Authors:  Raf Bisschops; Miguel Areia; Emmanuel Coron; Daniela Dobru; Bernd Kaskas; Roman Kuvaev; Oliver Pech; Krish Ragunath; Bas Weusten; Pietro Familiari; Dirk Domagk; Roland Valori; Michal F Kaminski; Cristiano Spada; Michael Bretthauer; Cathy Bennett; Carlo Senore; Mário Dinis-Ribeiro; Matthew D Rutter
Journal:  United European Gastroenterol J       Date:  2016-08-21       Impact factor: 4.623

9.  High-resolution imaging in Barrett's esophagus: a novel, low-cost endoscopic microscope.

Authors:  Timothy J Muldoon; Sharmila Anandasabapathy; Dipen Maru; Rebecca Richards-Kortum
Journal:  Gastrointest Endosc       Date:  2008-10       Impact factor: 9.427

Review 10.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.